Fisher Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,000
Closed -$10.9K 1013
2023
Q4
$10.9K Buy
+10,000
New +$10.9K ﹤0.01% 979